CEGEDIM-RELATIONSHIP
5.6.2014 18:01:21 CEST | Business Wire | Pressemeddelelse
Cegedim Relationship Management today announced that it has entered into a strategic partnership with Scribe Software , a recent winner of the prestigious Globee and Red Herring Top 100 awards, and now one of the fastest-growing cloud and software providers of data integration in the world. Leveraging Scribe’s innovative data integration platform, Cegedim customers will be able to cost-effectively and seamlessly move and integrate data between Cegedim Relationship Management and other enterprise applications without needing to create and maintain custom or code-based integrations.
Open Solutions and End-to-End Data Integration for Growth and
Increased Effectiveness
To remain competitive in today’s
market, Life Sciences companies must be able to achieve a 360-degree
view of all business-critical data. Creating and maintaining custom
integrations between various enterprise applications can be costly and
labor intensive. As a viable alternative, Scribe offers cost-effective
data integration connectors, providing access and insights into all
systems data for increased efficiency and growth.
According to the terms of the partnership, Scribe will initially provide data integration connectors to six of Cegedim’s key product offerings:
- Mobile Intelligence Life Sciences Customer Relationship Management (CRM)
- AggregateSpend360 market-leading transparency and disclosure solution
- Nucleus 360 Master Data Management solution
- Organization Manager for territory alignment
- Docnet healthcare professional portal
- Sample Guardian for compliant sample management
“Our customers are demanding more open systems with deeper integration,” said Laurent Labrune, Chief Executive Officer of Cegedim Relationship Management. “Not only will our partnership with Scribe Software solve a costly technical issue for our customers, but it will also enable more efficient multi-channel marketing, customer engagement, transparency and disclosure reporting – all imperatives facing the industry today.”
New Scribe connectors will be made available quarterly to empower Cegedim to meet the ongoing data integration needs of their customers. Additionally, Cegedim will be able to leverage the Scribe data integration platform to easily develop custom data integration connectors to meet unique customer needs and requirements.
“Seamless data and system integration is the next frontier in achieving the connected enterprise vision,” said Lou Guercia , Chief Executive Officer of Scribe Software . “We are excited to be working with Cegedim to bring the benefits of integration to their Life Sciences customers and expand Scribe’s global foothold.”
| About Cegedim Relationship Management: |
Cegedim Relationship Management is the Life Sciences industry’s
leading provider of Customer Relationship Management (CRM)
solutions. Designed specifically for Life Sciences, the company’s
innovative business solutions incorporate a thorough understanding
of local, regional and worldwide trends. Cegedim Relationship
Management enables approximately 200,000 users in many of the
world’s most innovative companies to stay ahead of market
challenges. In addition to CRM, Cegedim Relationship Management
also provides marketing, data optimization and regulatory
compliance solutions in more than 80 countries. Cegedim
Relationship Management is part of the France-based Cegedim S.A.
Group. Follow Cegedim Relationship Management on LinkedIn and Twitter . |
|
|
About Scribe
Software |
Scribe is an established global provider of solutions that easily
bring customer data anywhere it is needed – regardless of IT
infrastructure. Scribe’s award-winning products help 12,000
customers and 1,200 partners use customer data – cloud-based,
on-premise or a mix – to increase revenue, provide superior
service, and create business value faster. Its easy-to-use,
enterprise-ready solutions are backed by extensive support options
and training, and service customers across a wide array of
industries including financial services, life sciences,
manufacturing, and media and entertainment companies. |
|
| About Cegedim: |
Founded in 1969, Cegedim is a global technology and services
company specializing in the healthcare field. Cegedim supplies
services, technological tools, specialized software, data flow
management services and databases. Its offerings are targeted
notably at healthcare industries, life sciences companies,
healthcare professionals and insurance companies. The world leader
in life sciences CRM, Cegedim is also one of the leading suppliers
of strategic healthcare industry data. Cegedim employs 8,000
people in more than 80 countries and generated revenue of €902
million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM). Follow Cegedim on Twitter: @CegedimGroup . |
|
Contact:
Drew BUSTOS
Cegedim Relationship Management
Global
Communications
Tel.: +1 (908) 443.2451
drew.bustos@cegedim.com
or
Dan
MACLEOD
Scratch Marketing + Media for Scribe
Tel : +1
(240) 603.2887
dan@scratchmm.com
or
Aude
BALLEYDIER
Cegedim
Media Relations
Tel.: +33 (0)1 49
09 68 81
aude.balleydier@cegedim.fr
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Lattice to Showcase Industry-Leading FPGA Innovations at FPGA Conference Europe 202616.6.2026 22:00:00 CEST | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its exhibition plan for the upcoming FPGA Conference Europe. Lattice will participate in various speaker sessions to showcase how low power FPGAs are driving innovation across multiple sectors. The company will also demonstrate its latest FPGA technology advancements in physical AI, advanced connectivity, security, and more. Who: Lattice Semiconductor What / When (GMT+2): June 30 – July 2: Lattice Presentations & Demo Showcase Speaker sessions: Day 1 – 3 Speaker Sessions: Lattice FPGA deep dive sessions spanning physical AI, advanced connectivity, security, and design tools Date Time Session June 30 9:45 a.m. FPGA Verification and Testing by Arrow 11:15 a.m. Trusted Resilience Edge: Unified FPGA-TPM for Post-Quantum Cryptography RED & Cyber Resilience Act 12 p.m. SIPHashIP for Embedded Security: Enabling RED Compliance and CRA Readiness in Smart AR/VR Systems 2:15 p.m. Foundations of FPGA Security
IQM Deploys Its First U.S. Quantum Computer at Oak Ridge National Laboratory16.6.2026 20:53:00 CEST | Press release
Pathfinder, a 20-qubit IQM Radiance system, is now operational at the home of Frontier, the world's most powerful supercomputer for open science. It’s ORNL's first commercially procured quantum computer and IQM's first system on U.S. soil. It will be connected to high-performance computing systems in the National Center for Computational Sciences Technology Integration Group's test bed. ORNL owns and operates the system on its own campus. IQM's deployment model gives customers direct ownership and control of their quantum infrastructure, including the IP. IQM has sold 23 full-stack quantum systems worldwide, more on-premises systems than any other manufacturer. The deployment expands IQM's commercial presence in the United States ahead of its planned Nasdaq listing through its merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). The Department of Energy's Oak Ridge National Laboratory (ORNL) today launched Pathfinder, the first commercially procured quantum computer at ORNL, built
Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology16.6.2026 19:00:00 CEST | Press release
Court orders Siemens to halt production and recall and destroy products across Germany, France and the Netherlands Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens’ latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the market, using or importing or storing for those purposes its MAMMOMAT B.brilliant systems across Germany, France and the Netherlands, as well as monetary damages and penalties for non-compliance. The court also required Siemens to execute a mandatory recall and destruction of all affected systems in those countries. On June 10, 2026, the UPC determined that Siemens infringed upon European Patent EP 2 352 431, Hologic’s Focusing Technology on the Envision™ Platform, the first FDA-approved mammography innovation of its kind.1
RealTime Reservation Acquires STAY to Create Leading Global Guest Experience Platform Serving 2,000+ Properties Across 75+ Countries16.6.2026 18:30:00 CEST | Press release
Wavecrest Growth Partners invests to enable combination and support growth of the combined company RealTime Reservation (RTR), the industry leader in dynamic hospitality booking technology for onsite activities, amenities, and ancillary revenue management, today announced its acquisition of STAY, creating a global end-to-end guest experience platform for the hospitality industry. The combined company will serve more than 2,000 hospitality properties across 75+ countries throughout North America, Europe, Latin America and the Caribbean. The combination significantly expands RTR's international footprint and strengthens its position as a leading provider of guest engagement, ancillary revenue, and guest experience technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616258776/en/ Pictured: RealTime Reservation's dynamic booking interface allows hotel guests to select and reserve pool and beach amenities by location, d
Happy Holidays S.A. and JTA Investment Holding Announce €65 Million Investment for SARTIMARE Tourism Development in Greece16.6.2026 17:42:00 CEST | Press release
Happy Holidays S.A. today announced the signing of an Investment Agreement with Qatar-based JTA Investment Holding for the development of the sustainable SARTIMARE Beach Resort & Spa project in Sarti, Halkidiki, Greece. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616892834/en/ Dr. Amir Ali Salemi Zadeh, CEO of JTA Investment Holding and Georgios Iosifidis, Founder & Owner of Happy Holidays S.A. Under the agreement, JTA Investment Holding will invest €65 million into the development. The project will be built on a site of approximately 120,900 square meters, with construction scheduled between 2027 and 2030. Designed with a strong commitment to environmental responsibility, the SARTIMARE project will feature luxury hospitality facilities, premium residences and villas, wellness amenities, retail, food & beverage outlets, and marina infrastructure. The project's valuation is expected to exceed €100 million as key develop
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum